Commercialization Support
Service · Consulting & advisory by Cencora
Accelerate your path to market with global expertise and integrated commercialization solutions.
Cencora Commercialization Support provides pharmaceutical and biopharma companies with end-to-end strategic solutions to launch and scale therapies globally. It offers specialized expertise in market access, field reimbursement, and targeted marketing to accelerate speed-to-market and improve patient access.
Category: Management Consulting
- Industries served
- Pharmaceutical and biopharma companies
- Global Presence
- 50+ countries
- Worldwide Locations
- 1,300+ locations
- Target Audience
- Pharmaceutical and biopharma manufacturers
- Therapeutic Focus
- Oncology, Rare Disease, CGT, Biosimilars
- Global presence in over 50 countries
- 1,300+ locations worldwide
- Specialized expertise in oncology and rare diseases
- CustomConnect targeted marketing program
Overview
Cencora Commercialization Support is a suite of strategic solutions designed for pharmaceutical and biopharma companies to bring therapies to market effectively. The service assists manufacturers of all sizes in navigating the product lifecycle, from early discovery and clinical development to post-launch support. It addresses critical market access challenges through field reimbursement specialists who educate providers on payer issues and claim submissions. Cencora leverages a global network of over 1,300 locations across more than 50 countries to provide local market insights and logistics. Specialized expertise is available for complex therapeutic areas including oncology, rare diseases, and cell and gene therapies. By integrating distribution, marketing, and patient access strategies, the service helps manufacturers maximize product potential and accelerate speed-to-market.
Strategic Launch Solutions
- Launch Readiness Support: Cencora provides strategic and integrated solutions to build a foundation for successful product launches across the globe.
- Speed-to-Market Acceleration: The service helps manufacturers accelerate speed-to-market and maximize product potential through global expertise.
- Rare Disease Support: Cencora offers specialized expertise for research, manufacturing, storage, and shipping for rare and orphan therapies.
- CGT Commercialization: Integrated support is available to help biopharma companies accelerate the path from discovery to commercialization for cell and gene therapies.
Market Access and Marketing
- CustomConnect Marketing: The CustomConnect marketing program connects brand messages with relevant healthcare decision makers through highly targeted outreach.
- Field Reimbursement Support: Field reimbursement specialists educate providers on payer issues, coding changes, and claim submission processes.
- Value Proposition Delivery: Cencora provides solutions to help identify, demonstrate, and deliver a brand’s value proposition to key stakeholders.
- Patient Access Strategies: The service includes patient access and adherence support to address barriers and increase speed-to-therapy.
Therapeutic and Product Expertise
- Biosimilar Commercialization: Cencora offers expertise in biosimilar distribution to help manufacturers navigate the evolving market for cost-effective therapies.
- Oncology Expertise: Tailored strategies and global expertise are provided for oncology therapies to ensure faster market entry.
- Mature Product Outsourcing: Strategic and operational support is available on a global scale to unlock greater value for mature product portfolios.
- Specialty Product Support: The service supports brand and specialty products with integrated distribution and commercialization strategies.
What's included
- Launch readiness, market access, field reimbursement, targeted marketing, and therapeutic-specific support
Use cases
- Pharmaceutical companies use launch readiness support to build a strategic foundation for successful global product rollouts.
- Manufacturers deploy field reimbursement specialists to educate healthcare providers on complex payer issues and coding changes.
- Biopharma firms leverage specialized logistics and patient support to commercialize cell and gene therapies.
- Brand managers use CustomConnect to deliver targeted marketing messages directly to relevant healthcare decision makers.
Specifications
- Industries served
- Pharmaceutical and biopharma companies
- Availability
- Global presence in over 50 countries with 1,300+ locations worldwide
- Global Presence
- 50+ countries
- Worldwide Locations
- 1,300+ locations
- Target Audience
- Pharmaceutical and biopharma manufacturers
- Therapeutic Focus
- Oncology, Rare Disease, CGT, Biosimilars
FAQ
How does Cencora support new product launches?
Cencora provides strategic, integrated solutions to build a foundation for successful product launches across the globe, helping manufacturers accelerate their speed-to-market.
What is CustomConnect marketing?
CustomConnect is a highly targeted marketing program that connects brand messages with relevant healthcare decision makers to increase awareness of therapies.
What role do field reimbursement specialists play?
Field reimbursement specialists educate healthcare providers on payer issues, coding changes, and the claim submission process to improve patient access.
What support is available for cell and gene therapies?
Cencora offers integrated support for biopharma companies to accelerate the path from discovery to commercialization, including specialty logistics and patient support.
Added by AntSpace from public sources (cencora.com).